BioCryst Pharmaceuticals
BCRX
6,63 €
Share price
-1.35%
Change (1 day)
50.97%
Change (1 year)
Categories
Revenue for BioCryst Pharmaceuticals (BCRX)
Revenue in 2024 (TTM): €0.41 Billion
According to BioCryst Pharmaceuticals
's latest financial reports the company's current revenue (TTM 
) is €0.40 Billion. an increase over the revenue in the year 2023 that were of €0.29 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BioCryst Pharmaceuticals from 1996 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | €0.43 B | 44.47% |
| 2023 | €0.29 B | 18.74% |
| 2022 | €0.25 B | 81.93% |
| 2021 | €0.13 B | 858.34% |
| 2020 | €14.48 M | -66.78% |
| 2019 | €43.59 M | 141.47% |
| 2018 | €18.05 M | -13.99% |
| 2017 | €20.99 M | -16.22% |
| 2016 | €25.05 M | -43.23% |
| 2015 | €44.13 M | 294.45% |
| 2014 | €11.18 M | -10.84% |
| 2013 | €12.54 M | -36.86% |
| 2012 | €19.87 M | 31.41% |
| 2011 | €15.12 M | -67.75% |
| 2010 | €46.89 M | -9.92% |
| 2009 | €52.06 M | 28.68% |
| 2008 | €40.45 M | -17.07% |
| 2007 | €48.78 M | 936.52% |
| 2006 | €4.7 M | 3571.61% |
| 2005 | €0.12 M | 1853.77% |
| 2004 | €0 M | -99.49% |
| 2003 | €1.29 M | -23.55% |
| 2002 | €1.69 M | -86.56% |
| 2001 | €12.63 M | 944.39% |
| 2000 | €1.2 M | -54.8% |
| 1999 | €2.67 M | -51.88% |
| 1998 | €5.56 M | 450% |
| 1997 | €1.01 M | -53.85% |
| 1996 | €2.19 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | €0.57 B | 40.76% | 🇺🇸 USA |
 | €1.72 B | 321.99% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |
 | €0.61 B | 51.35% | 🇺🇸 USA |
 | €26.01 B | 6,279.46% | 🇺🇸 USA |
 | €6.35 M | -98.44% | 🇺🇸 USA |
 | €36.35 B | 8,814.91% | 🇬🇧 UK |
 | €0.91 B | 124.89% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |